European Trial of Immunosuppression in SPK Tx

PHASE3CompletedINTERVENTIONAL
Enrollment

228

Participants

Timeline

Start Date

February 28, 2002

Study Completion Date

September 30, 2005

Conditions
Diabetes Mellitus, Type 1Diabetic Nephropathy
Interventions
DRUG

sirolimus versus mycophenolate mofetil

Trial Locations (14)

1200

Cliniques Universitaires Saint Luc, Brussels

1211

Hôpital Cantonal de Geneve, Geneva

3000

UZ Gasthuisberg, Leuven

6020

Universitätsklinik, Innsbruck

9000

UZ Gent, Ghent

13353

Charite Campus Virchow Klinikum, Berlin

14021

Institute for clinical and experimental medicine-IKEM, Prague

44892

Knappschaftskrankenhaus, Langendreer

60590

Goethe University, Frankfurt am Main

64239

Tel Aviv Sourasky Medical Center, Tel Aviv

79111

Chirurgische Universitätsklinik, Freiburg im Breisgau

81366

Klinikum Grosshadern-University of Munich, Munich

90336

Klinikum Innenstadt der Universität München, Munich

08036

Hospital Clinico, Barcelona

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Fujisawa GmbH

INDUSTRY

collaborator

Hoffmann-La Roche

INDUSTRY

collaborator

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

collaborator

Neovii Biotech

INDUSTRY

collaborator

Genzyme, a Sanofi Company

INDUSTRY

lead

EUROSPK Study Group

OTHER